James E. Baumgartner

AdventHealth Orlando

Papers

2

Total Citations

62

H-Index

2

About

James E. Baumgartner is a leading neurosurgeon and researcher whose work centers on the surgical treatment of drug-resistant epilepsy, with a particular focus on minimally invasive techniques. He is best known for his pioneering contributions to laser interstitial thermal therapy (LITT), a procedure that uses heat to precisely ablate epileptic foci in the brain. His landmark prospective multicenter study on LITT for drug-resistant epilepsy, which reported one-year outcomes in 2020 and has garnered 53 citations, demonstrated significant improvements in seizure control and quality of life, establishing LITT as a viable alternative to traditional open surgery. More recently, his 2025 study on LITT for mesial temporal lobe epilepsy, with 9 citations, further refines our understanding of clinical and procedural outcomes in this challenging patient population. Dr. Baumgartner’s work has been instrumental in advancing the field of epilepsy surgery, offering patients a less invasive option with reduced recovery times. His research continues to shape clinical guidelines and inspire a new generation of neurosurgeons dedicated to improving outcomes for those with refractory epilepsy.

Research Focus

Key Achievements

2
H-Index
2
Papers
62
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
A prospective multicenter study of laser ablation for drug resistant epilepsy – One year outcomes
53 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: AdventHealth Orlando

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago